This inventor holds 3 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2017
Title: Horacio F Cantiello: Innovator in Gene Alteration Tools
Introduction
Horacio F Cantiello is a notable inventor based in Rowley, MA (US). He has made significant contributions to the field of gene alteration through his innovative work. With a total of 3 patents, Cantiello has established himself as a key figure in biotechnology.
Latest Patents
Cantiello's latest patents focus on oligonucleotide complex compositions and methods of use as gene alteration tools. These compositions and methods provide treatments for altering the phenotype of a cell by administering an oligonucleotide complex. The complex consists of two strands with specific chemical modifications, showcasing his expertise in genetic engineering.
Career Highlights
Cantiello is associated with The General Hospital Corporation, where he continues to advance research in gene therapy. His work has the potential to revolutionize treatments for various genetic conditions, making a lasting impact on the medical field.
Collaborations
Cantiello has collaborated with esteemed colleagues such as David R Tabatadze and Paul C Zamecnik. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Horacio F Cantiello's contributions to gene alteration tools exemplify the intersection of innovation and biotechnology. His work continues to pave the way for advancements in genetic treatments, highlighting the importance of research in improving human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile